ZBP1 and neoplasm: Consistent with the observations from the MOC1 transplantation models, Zbp1−/− mice demonstrated a significantly reduced tumor burden, thereby reinforcing the model-independent inhibitory role of ZBP1 deficiency in the progression of OSCC.